Assistance Publique Hopitaux De Paris

At Assistance Publique Hopitaux De Paris, a major focus is cardiology research across cardiovascular diseases, with studies in atherosclerotic cardiovascular disease, atrial fibrillation, heart failure, hypertrophic cardiomyopathy, and transcatheter aortic valve implantation-related care. These trials are designed to test new treatments, improve prevention, and reduce serious cardiac events.

• Preventing major cardiovascular events in high-risk patients
• Evaluating therapies for atrial fibrillation and stroke prevention
• Studying heart failure, inflammation, and structural heart disease

The site is also involved in research on lipid-related risk factors such as elevated lipoprotein(a) and severe hypertriglyceridemia, reflecting a broad effort to improve long-term cardiovascular outcomes.

Clinical trials in nervous system diseases at this Paris hospital include work on early Alzheimer’s disease, multiple sclerosis, idiopathic hypersomnia, and glioblastoma. The research aims to better understand disease progression, support symptom control, and assess whether new therapies can improve daily function and survival.

• Testing treatments for early cognitive decline
• Comparing disease-modifying approaches in relapsing multiple sclerosis
• Improving diagnosis and management of aggressive brain tumors

The portfolio also includes studies of sleep-related disorders and advanced imaging tools, showing interest in both treatment and diagnosis within neurology.

A substantial part of the research landscape covers neoplasms and hemic and lymphatic diseases, including acute myeloid leukemia, myelodysplastic syndrome, B-cell malignancies, Richter syndrome, and several solid tumors such as head and neck cancer, prostate cancer, and renal cell carcinoma. These trials are focused on testing new cancer therapies, improving survival, and refining treatment strategies.

• Evaluating novel combinations for blood cancers
• Studying treatment options for recurrent or advanced solid tumors
• Exploring ways to improve outcomes after surgery or standard therapy

The site also supports research into tumor imaging and device-based approaches, highlighting a strong interest in both cancer treatment and clinical innovation.

Research in immune system diseases and related inflammatory conditions includes idiopathic inflammatory myopathy, Sjögren’s syndrome, uveitis, progressive multifocal leukoencephalopathy in immunocompromised patients, and acquired hemophagocytic syndrome. These studies aim to evaluate new therapies, control inflammation, and improve safety in complex immune-mediated illness.

• Assessing treatment effectiveness in autoimmune and inflammatory disease
• Studying eye inflammation and vision-threatening complications
• Investigating immune-based approaches in critically ill or immunocompromised patients

This work reflects a broad interest in balancing immune modulation with patient safety across multiple specialties.

The site also conducts trials in digestive system diseases and nutritional and metabolic diseases, including hepatic encephalopathy, inflammatory liver adenomas, and severe hypertriglyceridemia. These studies are intended to improve symptom control, prevent complications, and evaluate new treatment options for liver and metabolic disorders.

• Testing therapies to delay liver-related hospitalizations
• Studying new approaches for inflammatory liver conditions
• Evaluating treatments that lower metabolic and cardiovascular risk

At Assistance Publique Hopitaux De Paris, this area links internal medicine with cardiology through research on shared risk factors and long-term disease prevention.

Additional trials span mental disorders and specialized diagnostic research, including treatment-resistant depression and advanced imaging for low-grade glioma. The goal is to test new therapeutic options while also improving how difficult-to-classify diseases are detected and characterized.

• Exploring new options for difficult-to-treat depression
• Improving imaging-based diagnosis in brain tumors
• Supporting precision medicine across complex and uncommon conditions

This mix of psychiatric and diagnostic studies adds depth to the site’s broader research profile, showing engagement with both treatment development and better disease classification.